|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1998-1-8
|
|
pubmed:abstractText |
Suramin disrupts several kinds of growth factor receptors. Since human esophageal squamous cell carcinoma expresses abundant epidermal growth factor receptors (EGFR) and proliferates in an autocrine and paracrine manner, it was expected that suramin inhibits tumor growth by disrupting EGFR.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0036-5521
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
824-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9282976-Animals,
pubmed-meshheading:9282976-Antineoplastic Agents,
pubmed-meshheading:9282976-Carcinoma, Squamous Cell,
pubmed-meshheading:9282976-Cell Division,
pubmed-meshheading:9282976-Disease Models, Animal,
pubmed-meshheading:9282976-Dose-Response Relationship, Drug,
pubmed-meshheading:9282976-Epidermal Growth Factor,
pubmed-meshheading:9282976-Esophageal Neoplasms,
pubmed-meshheading:9282976-Humans,
pubmed-meshheading:9282976-Immunoblotting,
pubmed-meshheading:9282976-Immunohistochemistry,
pubmed-meshheading:9282976-Injections, Intravenous,
pubmed-meshheading:9282976-Male,
pubmed-meshheading:9282976-Mice,
pubmed-meshheading:9282976-Mice, Nude,
pubmed-meshheading:9282976-Neoplasm Transplantation,
pubmed-meshheading:9282976-Reference Values,
pubmed-meshheading:9282976-Suramin,
pubmed-meshheading:9282976-Tumor Cells, Cultured
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Effect of suramin on human esophageal cancer cells in vitro and in vivo.
|
|
pubmed:affiliation |
First Dept. of Surgery, Okayama University Medical School, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
